Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | USP2 | O75604 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | ELANE | P08246 | 1/20 | 0.43 |
| ▸ | CTSG | P08311 | 1/20 | 0.43 |
| ▸ | CTRC | Q99895 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11470645 | 0.89 | MAPT (0.40) | MAPTGAAMEN1USP2KMT2A | |
| SCHEMBL3420629 | 0.86 | MAPT (0.49) | MAPTGAAMEN1USP2KMT2A | |
| SCHEMBL5014433 | 0.84 | MAPT (0.51) | MAPTGAAMEN1USP2KMT2A | |
| SCHEMBL4580230 | 0.82 | MAPT (0.54) | MAPTGAAMEN1USP2KMT2A | |
| SCHEMBL8121430 | 0.82 | MAPT (0.54) | MAPTGAAMEN1USP2KMT2A | |
| SCHEMBL4578069 | 0.82 | MAPT (0.54) | MAPTGAAMEN1USP2KMT2A | |
| SCHEMBL12101788 | 0.82 | MAPT (0.50) | MAPTGAAMEN1USP2KMT2A | |
| SCHEMBL5450752 | 0.82 | MAPT (0.54) | MAPTGAAMEN1USP2KMT2A | |
| SCHEMBL8115352 | 0.82 | MAPT (0.54) | MAPTGAAMEN1USP2KMT2A | |
| SCHEMBL6162730 | 0.81 | MAPT (0.35) | MAPTGAAMEN1USP2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8853297-B2 | Method and means for infiltrating enamel lesions | CHARITE UNIVERSITATSMEDIZIN BERLIN (DE) | 2014-10-07 | — | — | US | claimed |
| US-20090304622-A1 | METHOD AND MEANS FOR INFILTRATING ENAMEL LESIONS | CHARITE-UNIVERSITATSMEDIZIN BERLIN (DE) | 2009-12-10 | — | — | US | claimed |
| EP-2023884-A1 | METHOD AND MEANS FOR INFILTRATING ENAMEL LESIONS | Ernst Mühlbauer GmbH & Co.KG (DE) | 2009-02-18 | — | — | EP | claimed |
| WO-2007131725-A1 | METHOD AND MEANS FOR INFILTRATING ENAMEL LESIONS | CHARITE-UNIVERSITÄTSMEDIZIN BERLIN (DE) | 2007-11-22 | — | — | WO | claimed |
| US-20260069510-A1 | DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT COMPOSITION | SHOFU INC. (JP) | 2026-03-12 | — | — | US | disclosed |
| EP-3733152-B1 | POWDER-LIQUID TYPE RESIN-REINFORCED DENTAL GLASS IONOMER CEMENT COMPOSITION | SHOFU INC (JP) | 2026-03-11 | — | — | EP | disclosed |
| US-20260060900-A1 | DENTAL COMPOSITE RESIN KIT | SHOFU INC. (JP) | 2026-03-05 | — | — | US | disclosed |
| EP-4659729-A1 | DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT COMPOSITION | Shofu Inc. (JP) | 2025-12-10 | — | — | EP | disclosed |
| US-20250195339-A1 | DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT COMPOSITION | SHOFU INC. (JP) | 2025-06-19 | — | — | US | disclosed |
| US-20250195336-A1 | DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT COMPOSITION FOR LUTING EXCELLENT IN ADHESIVE PROPERTY AND REMOVABILITY OF EXCESS CEMENT | SHOFU INC. (JP) | 2025-06-19 | — | — | US | disclosed |
| EP-4541338-A1 | DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT COMPOSITION CONTAINING ORGANIC FILLER | Shofu Inc. (JP) | 2025-04-23 | — | — | EP | disclosed |
| EP-4537805-A1 | DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT COMPOSITION FOR LUTING EXCELLENT IN ADHESIVE PROPERTY AND REMOVABILITY OF EXCESS CEMENT | Shofu Inc. (JP) | 2025-04-16 | — | — | EP | disclosed |
| EP-0266882-A2 | Second harmonic generation with N,N'-substituted barbituric acids | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1988-05-11 | — | — | EP | disclosed |
| US-4714838-A | USING LASER AS SOURCE OF COHERENT LIGHT | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1987-12-22 | — | — | US | disclosed |
| US-4636282-A | PRINTED CIRCUITS, GUANIDINE DERIVATIVES | GREAT LAKES CHEMICAL CORPORATION (US) | 1987-01-13 | — | — | US | disclosed |
| CN-85104237-A | The preparation method of 3-amino-pyrazol base (3,4-d) pyrimidine derivatives | — | 1986-12-03 | — | — | CN | disclosed |
| US-4603203-A | ANTIINFLAMMATORY, ANALGESIC AND ANTIPYRETIC AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1986-07-29 | — | — | US | disclosed |
| EP-0166054-A1 | 3-Aminopyrazolo(3,4-d)pyrimidine derivatives and production thereof | Takeda Chemical Industries, Ltd. (JP) | 1986-01-02 | — | — | EP | disclosed |
| US-4382983-A | PARTIALLY HYDROLYZED SILOXANE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-05-10 | — | — | US | disclosed |
| US-4031218-A | BRONCHODILATOR | MALLINCKRODT, INC. (US) | 1977-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069510-A1 | DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT COMPOSITION | GRIN3A, HBG1, ASIC1 | MAPT 2952/4885GAA 1438/4885MEN1 3431/4885 |
| US-20250195336-A1 | DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT COMPOSITION FOR LUTING EXCELLENT IN ADHESIVE PROPERTY AND REMOVABILITY OF EXCESS CEMENT | BRWD1, ITGA8, PLA2G2C | MAPT 1937/4885GAA 2869/4885MEN1 4718/4885 |
| US-20260060900-A1 | DENTAL COMPOSITE RESIN KIT | BOLA2; BOLA2B, LBR, COL2A1 | MAPT 2976/4885GAA 1077/4885MEN1 2022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.